People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spinal Singularity, Inc. | — | Biotechnology | Seed | $4.9M | $88.6M | 2018 |
| American Telecare Inc | — | Other Health Care | Seed | $1.4M | $33.5M | 2009 |
David Kaysen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Kaysen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Baker | 1 | 3 |
| Derek Herrera | 1 | 2 |
| Andrew Gilbert | 1 | 2 |
| Michael O'Sullivan | 1 | 2 |
| Bill Colone | 1 | 2 |
| Christopher Jennings | 1 | 2 |
| Michael Chappuis | 1 | 1 |
| Kenneth Bloem | 1 | 1 |
| Michael Brodeur | 1 | 1 |
| Randall S. Moore | 1 | 1 |
| Joseph McErlane | 1 | 1 |
| Alan Lenzmeier | 1 | 1 |
| Lance Piccolo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.